A new pancreatic cancer drug is changing survival rates for one of the deadliest cancers
A new pancreatic cancer drug, daraxonrasib, is showing impressive results, nearly doubling survival in early trials. Here’s what doctors say.
Good news, useful optimism, and meaningful progress from around the world.
A new pancreatic cancer drug, daraxonrasib, is showing impressive results, nearly doubling survival in early trials. Here’s what doctors say.
Researchers at Texas A&M have developed a nasal spray that appears to reverse brain aging by calming inflammation and restoring the brain’s energy systems. After just...
AI has been used to develop a "fundamentally new" type of vaccine that could protect against large swathes of viruses and prevent pandemics, say researchers.
The team has developed ultrathin, semi-transparent perovskite solar cells that are 50 times thinner than conventional perovskite solar cells.
Scientists have demonstrated a new plasma operating regime that could help solve two of fusion energy’s biggest challenges at once.
The process significantly lowers the extreme heating requirements of cement manufacturing by incorporating a preheating electrochemical conversion step.
A newly identified enzyme called IDOL could become a major new target in the fight against Alzheimer’s disease. Researchers found that removing it from neurons sharply...
Low vitamin D levels could be quietly making breast cancer surgery recovery far more painful. In a new study, patients deficient in vitamin D were three times more...
In the new study, published May 14 in the journal Science, the scientists demonstrated that ultralow-power switching in the picosecond range was possible.
Scientists have identified a protein that appears to put the brakes on the chronic inflammation linked to aging. Older mice with boosted levels of the protein were...
A new DNA test could help screen whether patients require the treatment or not, according to a new international trial.
Researchers discovered cells release the protein in response to damaged neurons. In early experiments, antibodies that blocked GPNMB stopped the toxic process from...